Table 1 Baseline characteristics of study population.

From: Post-intensive care syndrome and health-related quality of life in long-term survivors of cardiac arrest: a prospective cohort study

Sociodemographics

 

N

107

Age, median (IQR)

62.4 (54.3, 71.9)

Female sex, n (%)

18 (16.8)

Relationship, n (%)

88 (83.0)

Children, n (%)

88 (82.2)

Highest education

 School, n (%)

9 (8.4)

 Diploma/apprenticeship, n (%)

71 (66.4)

 University, n (%)

17 (15.9)

 Unknown, n (%)

10 (9.3)

 Employed at baseline, n (%)

57 (54.8)

Comorbidities

 Coronary heart disease, n (%)

74 (69.2)

 Heart failure, n (%)

8 (7.5)

 COPD, n (%)

5 (4.7)

 Liver cirrhosis, n (%)

3 (2.8)

 Arterial hypertension, n (%)

53 (49.5)

 Diabetes, n (%)

13 (12.1)

 Chronic kidney disease, n (%)

6 (5.6)

 Neurological disease, n (%)

7 (6.5)

Severity of illness scores at ICU admission

 APACHE II score, median (IQR)

27.5 (23, 31)

 SAPS II score, median (IQR)

60 (47, 67)

Cardiac arrest characteristics

 Etiology: Acute coronary syndrome, n (%)

76 (72.4)

 Etiology: Rhythmogenic, n (%)

17 (16.2)

 Etiology: Other or unknown reason, n (%)

12 (11.4)

Setting of cardiac arrest

 At home, n (%)

35 (33.0)

 In public, n (%)

60 (56.6)

 IHCA, n (%)

11 (10.4)

 Observed cardiac arrest, n (%)

99 (92.5)

 Bystander CPR, n (%)

86 (80.4)

 Professional bystander CPR, n (%)

29 (52)

Initial rhythm

 VT, n (%)

6 (5.6)

 VF, n (%)

80 (74.8)

 Asystolie, n (%)

2 (1.9)

 PEA, n (%)

6 (5.6)

 Unknown, n (%)

13 (12.1)

 No-flow (min), median (IQR)

.5 (.5, 2)

 Low-flow (min), median (IQR)

13 (8, 20)

 Time until ROSC, median (IQR)

15 (10, 26)

Epinephrine during resuscitation

 No epinephrine, n (%)

54 (55)

 < 3 mg, n (%)

20 (20)

  ≥ 3 mg, n (%)

24 (24)

  1. APACHE II, acute physiology and chronic health evaluation score II; COPD, Chronic obstructive pulmonary disease; CPR, Cardiopulmonary resuscitation; IHCA In-hospital cardiac arrest; IQR Interquartile range; ROSC Return of spontaneous circulation; VF, ventricular fibrillation; VT, pulseless ventricular tachycardia; PEA, pulseless electrical activity; SAPS II, simplified acute physiology score II.